Patents by Inventor Andreas Vegge

Andreas Vegge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)
    Publication number: 20240067944
    Abstract: The present invention provides ISVD polypeptide derivatives capable of binding coagulation Factor IX(a) and Factor X(a) which are highly potent and provide a sufficiently long half-life such to allow for effective subcutaneous—as well as peroral administration. The ISVD polypeptides derivatives disclosed herein are thus suitable for treatment of haemophilia A, haemophilia A with inhibitors and acquired haemophilia A by various routes of administration including subcutaneous and peroral administration.
    Type: Application
    Filed: July 7, 2023
    Publication date: February 29, 2024
    Applicant: Novo Nordisk A/S
    Inventors: Andreas Vegge, Daniele Granata, Eva Johansson, Jais Rose Bjelke, Jacob Lund, Philip Jonas Sassene, Per J. Greisen, Thomas Egebjerg, Evelyn De Tavernier, Soren Steffensen, Marie-Ange Buyse, Frantisek Hubalek, Simone Fulle, Mathias Norrman
  • Systems and methods for liquid injection
    Patent number: 11771829
    Abstract: Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject) such as a liquid pharmaceutical agent.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: October 3, 2023
    Assignees: Massachusetts Institute of Technology, Novo Nordisk A/S, The Brigham and Women's Hospital, Inc.
    Inventors: Robert S. Langer, Carlo Giovanni Traverso, Alex G. Abramson, Morten Revsgaard Frederiksen, Mikkel Oliver Jespersen, Brian Mouridsen, Jesper Windum, Mette Poulsen, Brian Jensen, Jorrit Jeroen Water, Mikkel Wennemoes Hvitfeld Ley, Xiaoya Lu, Andreas Vegge
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Patent number: 11622996
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: April 11, 2023
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Publication number: 20230087952
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 16, 2022
    Publication date: March 23, 2023
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20230000949
    Abstract: The invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF(A) peptide, and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: January 5, 2023
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge, Kaisa Naelapaeae
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220395559
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist, an SLGT2 inhibitor, a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, and a hydrotrope. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 15, 2022
    Inventors: Kaisa Naelapaeae, Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220323544
    Abstract: The invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF(A) peptide, and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: August 7, 2020
    Publication date: October 13, 2022
    Inventors: Betty Lomstein Pedersen, Birgitte Nissen, Kaisa Naelapaeae, Andreas Vegge
  • SOLID COMPOSITION COMPRISING A PYY COMPOUND AND A SALT OF N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220280611
    Abstract: The present invention relates to a solid composition comprising a PYY compound and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: August 6, 2020
    Publication date: September 8, 2022
    Inventors: Andreas Vegge, Birgitte Schjellerup Wulff, Birgitte Nissen, Soeren Oestergaard, Betty Lomstein Pedersen
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220265777
    Abstract: The invention relates to solid pharmaceutical compositions comprising a GLP-1 agonist, an SGLT2 inhibitor and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: August 6, 2020
    Publication date: August 25, 2022
    Inventors: Betty Lomstein Pedersen, Birgitte Nissen, Patrick William Garibay, Kaisa Naelapaeae, Andreas Vegge
  • SOLID GLP-1 DERIVATIVE COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20220016216
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Application
    Filed: October 8, 2021
    Publication date: January 20, 2022
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard
  • Solid glp-1 derivative compositions for oral administration
    Patent number: 11167014
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: November 9, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Publication number: 20210236601
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: May 6, 2019
    Publication date: August 5, 2021
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20200147179
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Application
    Filed: June 11, 2018
    Publication date: May 14, 2020
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard